Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20161022030424N11
IRCT20161022030424N11
Recruiting
Phase 3

Effect of a medium-chain triglyceride (MCT)-Based Ketogenic Dietary Intervention along with high-dose intravenous ascorbic acid among overweight/obese patients with triple-negative breast cancer

Tabriz University of Medical Sciences0 sites240 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsTriple negative breast cancer.Malignant neoplasm of breast

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Triple negative breast cancer.
Sponsor
Tabriz University of Medical Sciences
Enrollment
240
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •18 to 70 years old
  • •Pathologically confirmed early\-stage triple\-negative breast cancer subtype
  • •1–3 positive axillary lymph nodes
  • •Histological grades I\-III
  • •Unilateral cancer
  • •A body mass index (BMI) of 25 kg/m2 and higher

Exclusion Criteria

  • •Serious cardiovascular disease
  • •Cognitive impairment
  • •Metabolic defects as a contraindication against ketogenic diet
  • •Who are considered unsuitable for the trial by the principal investigator because of abnormal blood indices or other reasons
  • •Use of systemic corticosteroids within one week of trial entry
  • •Receipt of chemotherapy within two week of trial entry
  • •Prior monoclonal antibody therapy within 1 month of trial entry

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Preventing the neurotoxic effects of hypoglycaemia in adolescents with Type 1 diabetes- a randomised placebo-controlled trial
ACTRN12617000780358Murdoch Childrens Research Institute10
Recruiting
Not Applicable
The effect of intaking medium- chain triglycerides in dysphagia patients
JPRN-UMIN000029528Tokyo Medical and Dental University35
Recruiting
Phase 2
Confirmation of effects of medium chain triglyceride therapy for citrin deficiencycitrin deficiencyEndocrinology and Metabolism, PediatricsD006111
JPRN-jRCTs041190017Mitsui Tetsuo50
Completed
Not Applicable
The Effects of Two Different Supplemental Oils on Keto-Adaptation and Symptoms of Carbohydrate Withdrawal
ACTRN12616001099415AUT University30
Recruiting
Not Applicable
Effect van MCT inname in gezonde persone
NL-OMON25246Amsterdam UMC AMC4